POLYPHARMACY USE AMONG PATIENTS WITH DIABETES- A CROSS-SECTIONAL RETROSPECTIVE STUDY
Author(s)
Alwhaibi M1, Balkhi B1, Alhawassi T1, Alkofide H1, Alduhaim N1, Alabdulali R1, Drweesh H1, Sambamoorthi U2
1King Saud University, Riyadh, Saudi Arabia, 2West Virginia University, Morgantown, WV, USA
OBJECTIVES : Patients with diabetes are at high risk for polypharmacy (i.e. use of multiple classes of medications) for treatment of diabetes, associated comorbidities, and other co-existing conditions. This study aims to estimate the prevalence of polypharmacy and factors associated with polypharmacy among adult patients with diabetes. METHODS : A cross-sectional retrospective observational study of adults with diabetes, who visited the outpatient clinic of a tertiary teaching hospital in Saudi Arabia, was conducted. Data were extracted from the Electronic Health Record (EHR) database for a period of twelve-month (January to December 2016). Polypharmacy was defined as the cumulative use of five or more medication classes. Polypharmacy among adults with diabetes was measured by calculating the average number of medication classes prescribed per patient. A multivariable logistic regression model was used to examine the factors associated with polypharmacy after adjusting for age, sex, marital status, nationality, and co-existing chronic conditions. RESULTS : A total of 8,932 adults with diabetes were included in this study. Of these, nearly 78 % had polypharmacy, which was more likely among women as compared to men and more likely among the elderly (age >
Conference/Value in Health Info
2018-05, ISPOR 2018, Baltimore, MD, USA
Value in Health, Vol. 21, S1 (May 2018)
Code
PDB20
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Diabetes/Endocrine/Metabolic Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now